Comparisons of detailed arterial healing response at seven months following implantation of an everolimus- or sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 960-966

  Sawada, Takahiro ^a   Shinke, Toshiro ^b   Otake, Hiromasa ^b   Mizoguchi, Taiji ^a   Iwasaki, Masamichi ^b   Emoto, Takuo ^a   Terashita, Daisuke ^a   Mizuguchi, Takao ^a   Okamoto, Hiroshi ^a   Matsuo, Yosuke ^a   Kim, Sushi Ku ^a   Takarada, Akira ^a   Yokoyama, Mitsuhiro ^a  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioscopy; Everolimus eluting stent; OCT; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; RAPAMYCIN; WARFARIN;

ADULT; AGED; ANGIOSCOPY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; HEALING; HEART PAPILLARY MUSCLE; HEART RUPTURE; HUMAN; INCIDENCE; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT RESPONSE;

ANGIOSCOPY; EVEROLIMUS-ELUTING STENT; OCT; STEMI;

AGED; AGED, 80 AND OVER; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84885314543     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.043     Document Type: Article

References (38)

1. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999;341:1949-56.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
3. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
4. Jensen LO,Maeng M, Thayssen P, et al. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with STsegment elevation myocardial infarction. Circ Cardiovasc Interv 2008;1:176-84.
5. Jensen LO, Maeng M, Kaltoft A, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007;50:463-70.
6. Nakazawa G, Finn AV, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008;118:1138-45.
7. Kubo T, Kitabata H, Kuroi A, et al. Comparison of vascular response after sirolimuseluting stent implantation between patients with unstable and stable angina pectoris. J Am Coll Cardiol Img 2008;1:475-84.
8. Kim JS, Fan C, Choi D, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation: 9-month follow-up optical coherence tomography study. Int J Cardiol 2011;146:341-6.
9. Van der Hoeven BL, Liem SS, Dijkstra J, et al. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction. Acute and 9-month intravascular ultrasound results of the MISSION! Intervention study. J Am Coll Cardiol Intv 2008;1:192-201.
10. Torguson R, Waksman R. Overview of the 2007 food and drug administration circulatory system devices panel meeting on the Xience V everolimus-eluting coronary stent. Am J Cardiol 2008;102:1624-30.
11. Inoue T, Shite J, Yoon J, et al. Optical coherence evaluation for everolimus-eluting stents at 8-months after implantation (cooperative Study with Korea). Heart 2011;97: 1379-84.
12. Choi HH, KimJS, Yoon DH, et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2012;28:491-7.
13. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;59:607-9.
14. Kaltoft A, Kelbaek H, Thuesen L, et al. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial. J Am Coll Cardiol 2010;56:641-5.
15. Vink MA, Dirksen MT, Suttorp MJ, et al. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. JACC Cardiovasc Interv 2011;4:24-9.
16. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28: 961-7.
17. Katoh H, Shite J, Shinke T, et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009;73: 1033-7.
18. Takano M, Murakami D, Yamamoto M, et al. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents. Int J Cardiol 2013;166:181-6.
19. Otake H, Shite J, Ako J, et al. Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC Cardiovasc Interv 2009;2:459-66.
20. Finn AV, JonerM, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis. Strut coverage as a marker of endothelialization. Circulation 2007;115: 2435-41.
21. Sakai S,Mizuno K, Yokoyama S, et al. Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study. JAmColl Cardiol 2003;42: 1558-65.
22. Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108-11.
23. AwataM, Nanto S, UematsuM, et al. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents. JACC Cardiovasc Interv 2009;2:453-8.
24. Den Heijer P, Foley DP, Hillege HL, et al. The 'Ermenoville' classification of observations at coronary angioscopy: Evaluation of intra-and inter-observer agreement: European Working Group on Coronary Angioscopy. Eur Heart J 1994;15:815-22.
25. Oyabu J,Ueda Y,OgasawaraN,Okada K,Hirayama A, Kodama K. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent vs bare metal stent. Am Heart J 2006;152:1168-74.
26. Stone GW, Lansky AJ, Pocock SJ, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009;360:1946-59.
27. Menichelli M, Parma A, Pucci E, et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 2007;49:1924-30.
28. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-104.
29. Joner M, Finn AV, Farb A, et al. Pathology of drug eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
30. Sera F, AwataM, UematsuM, Kotani J, Nanto S, Nagata S. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimuseluting stent implantation assessed by angioscopy. JACC Cardiovasc Interv 2009;2: 989-94.
31. Papayannis AC, Cipher D, Banerjee S, Brilakis ES. Optical coherence tomography evaluation of drug-eluting stents: a systemic review. Catheter Cardiovasc Interv 2013;81:481-7.
32. Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention 2009;5:157-65.
33. Planer D, Smits PC, KereiakesDJ, et al. Comparison of everolimus-and paclitaxel-eluting stents in patients with acute and stable coronary syndrome. JACC cadiovasc Interv 2011;4:1104-15.
34. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence froma comprehensive networkmeta-analysis. Lancet 2012;379:1393-402.
35. Sabate M, Cequier A, Iniguez A, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomized controlled trial. Lancet 2012;380:1482-90.
36. Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011;123:2954-63.
37. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-5.
38. Otsuka F. Pathologic features of everolimus-versus sirolimus-and paclitaxel-eluting stents in human coronary arteries. Presented at: Transcatheter Cardiovascular Therapeutics 2011; Nov. 7-12; San Francisco; 2011.